Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Lactate Inhibits Lipolysis in Fat Cells through Activation of an Orphan G-protein-coupled Receptor, GPR81*
Changlu Liu1,
Jiejun Wu,
Jessica Zhu,
Chester Kuei,
Jingxue Yu,
Jonathan Shelton,
Steven W. Sutton,
Xiaorong Li,
Su Jin Yun,
Taraneh Mirzadegan,
Curt Mazur2,
Fredrik Kamme3, , and
Timothy W. Lovenberg
Johnson & Johnson Pharmaceutical Research & Development, LLC, San Diego, California 92121
Abstract:
Lactic acid is a well known metabolic by-product of intenseexercise, particularly under anaerobic conditions. Lactate isalso a key source of energy and an important metabolic substrate,and it has also been hypothesized to be a signaling moleculedirecting metabolic activity. Here we show that GPR81, an orphanG-protein-coupled receptor highly expressed in fat, is in facta sensor for lactate. Lactate activates GPR81 in its physiologicalconcentration range of 1–20 mM and suppresses lipolysisin mouse, rat, and human adipocytes as well as in differentiated3T3-L1 cells. Adipocytes from GPR81-deficient mice lack an antilipolyticresponse to lactate but are responsive to other antilipolyticagents. Lactate specifically induces internalization of GPR81after receptor activation. Site-directed mutagenesis of GPR81coupled with homology modeling demonstrates that classicallyconserved key residues in the transmembrane binding domainsare responsible for interacting with lactate. Our results indicatethat lactate suppresses lipolysis in adipose tissue througha direct activation of GPR81. GPR81 may thus be an attractivetarget for the treatment of dyslipidemia and other metabolicdisorders.
Received for publication August 19, 2008.
Revision received October 25, 2008.
* The costs of publication of this article were defrayed in partby the payment of page charges. This article must thereforebe hereby marked "advertisement" in accordance with 18 U.S.C.Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org)contains supplemental Tables 1–3 and Figs. 1–6.
1 To whom correspondence should be addressed: Johnson & Johnson Pharmaceutical Research & Development, L.L.C., 3210 Merryfield Row, San Diego, CA 92121. Tel.: 858-784-3059; Fax: 858-450-2090; E-mail: cliu9{at}its.jnj.com.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
L. Bryan Ray (3 February 2009) Sci. Signal.2 (56), ec34.
[DOI: 10.1126/scisignal.256ec34] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Lactate Receptor Sites Link Neurotransmission, Neurovascular Coupling, and Brain Energy Metabolism.
K. H. Lauritzen, C. Morland, M. Puchades, S. Holm-Hansen, E. M. Hagelin, F. Lauritzen, H. Attramadal, J. Storm-Mathisen, A. Gjedde, and L. H. Bergersen (2013)
Cereb Cortex
|Abstract »|Full Text »|PDF »
Medium-chain Fatty Acid-sensing Receptor, GPR84, Is a Proinflammatory Receptor.
M. Suzuki, S. Takaishi, M. Nagasaki, Y. Onozawa, I. Iino, H. Maeda, T. Komai, and T. Oda (2013)
J. Biol. Chem.
288, 10684-10691
|Abstract »|Full Text »|PDF »
Naturally occurring HCA1 missense mutations result in loss of function: potential impact on lipid deposition.
J. R. Doyle, J. M. Lane, M. Beinborn, and A. S. Kopin (2013)
J. Lipid Res.
54, 823-830
|Abstract »|Full Text »|PDF »
Endogenous metabolites as ligands for G protein-coupled receptors modulating risk factors for metabolic and cardiovascular disease.
S. Tonack, C. Tang, and S. Offermanns (2013)
Am J Physiol Heart Circ Physiol
304, H501-H513
|Abstract »|Full Text »|PDF »
Hypoxia and Adipose Tissue Function and Dysfunction in Obesity.
Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs.
B. D. Hudson, E. Christiansen, I. G. Tikhonova, M. Grundmann, E. Kostenis, D. R. Adams, T. Ulven, and G. Milligan (2012)
FASEB J
26, 4951-4965
|Abstract »|Full Text »|PDF »
Oxidative stress-responsive microRNA-320 regulates glycolysis in diverse biological systems.
H. Tang, M. Lee, O. Sharpe, L. Salamone, E. J. Noonan, C. D. Hoang, S. Levine, W. H. Robinson, and J. B. Shrager (2012)
FASEB J
26, 4710-4721
|Abstract »|Full Text »|PDF »
3,5-Dihydroxybenzoic Acid, a Specific Agonist for Hydroxycarboxylic Acid 1, Inhibits Lipolysis in Adipocytes.
C. Liu, C. Kuei, J. Zhu, J. Yu, L. Zhang, A. Shih, T. Mirzadegan, J. Shelton, S. Sutton, M. A. Connelly, et al. (2012)
J. Pharmacol. Exp. Ther.
341, 794-801
|Abstract »|Full Text »|PDF »
Matched work high-intensity interval and continuous running induce similar increases in PGC-1{alpha} mRNA, AMPK, p38, and p53 phosphorylation in human skeletal muscle.
J. D. Bartlett, C. Hwa Joo, T.-S. Jeong, J. Louhelainen, A. J. Cochran, M. J. Gibala, W. Gregson, G. L. Close, B. Drust, and J. P. Morton (2012)
J Appl Physiol
112, 1135-1143
|Abstract »|Full Text »|PDF »
A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy.
J. Stebbing, A. Sharma, B. North, T. J. Athersuch, A. Zebrowski, D. Pchejetski, R. C. Coombes, J. K. Nicholson, and H. C. Keun (2012)
Ann. Onc.
23, 860-866
|Abstract »|Full Text »|PDF »
Metabolic characteristics of human subcutaneous abdominal adipose tissueafter overnight fast.
K. N. Frayn and S. M. Humphreys (2012)
Am J Physiol Endocrinol Metab
302, E468-E475
|Abstract »|Full Text »|PDF »
Deficiency of the GPR39 receptor is associated with obesity and altered adipocyte metabolism.
P. S. Petersen, C. Jin, A. N. Madsen, M. Rasmussen, R. Kuhre, K. L. Egerod, L. B. Nielsen, T. W. Schwartz, and B. Holst (2011)
FASEB J
25, 3803-3814
|Abstract »|Full Text »|PDF »
Study of GPR81, the Lactate Receptor, from Distant Species Identifies Residues and Motifs Critical for GPR81 Functions.
C. Kuei, J. Yu, J. Zhu, J. Wu, L. Zhang, A. Shih, T. Mirzadegan, T. Lovenberg, and C. Liu (2011)
Mol. Pharmacol.
80, 848-858
|Abstract »|Full Text »|PDF »
Extracellular Loop 2 of the Free Fatty Acid Receptor 2 Mediates Allosterism of a Phenylacetamide Ago-Allosteric Modulator.
N. J. Smith, R. J. Ward, L. A. Stoddart, B. D. Hudson, E. Kostenis, T. Ulven, J. C. Morris, C. Trankle, I. G. Tikhonova, D. R. Adams, et al. (2011)
Mol. Pharmacol.
80, 163-173
|Abstract »|Full Text »|PDF »
International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B).
S. Offermanns, S. L. Colletti, T. W. Lovenberg, G. Semple, A. Wise, and A. P. IJzerman (2011)
Pharmacol. Rev.
63, 269-290
|Abstract »|Full Text »|PDF »
IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid.
M. Yabu, H. Shime, H. Hara, T. Saito, M. Matsumoto, T. Seya, T. Akazawa, and N. Inoue (2011)
Int. Immunol.
23, 29-41
|Abstract »|Full Text »|PDF »
Molecular Basis for Agonism in the BB3 Receptor: An Epitope Located on the Interface of Transmembrane-III, -VI, and -VII.
F. Gbahou, B. Holst, and T. W. Schwartz (2010)
J. Pharmacol. Exp. Ther.
333, 51-59
|Abstract »|Full Text »|PDF »
Peroxisome Proliferator-Activated Receptor-{alpha} Control of Lipid and Glucose Metabolism in Human White Adipocytes.
C. Ribet, E. Montastier, C. Valle, V. Bezaire, A. Mazzucotelli, A. Mairal, N. Viguerie, and D. Langin (2010)
Endocrinology
151, 123-133
|Abstract »|Full Text »|PDF »
Peroxisome Proliferator-activated Receptor {gamma} Regulates Expression of the Anti-lipolytic G-protein-coupled Receptor 81 (GPR81/Gpr81).
E. H. Jeninga, A. Bugge, R. Nielsen, S. Kersten, N. Hamers, C. Dani, M. Wabitsch, R. Berger, H. G. Stunnenberg, S. Mandrup, et al. (2009)
J. Biol. Chem.
284, 26385-26393
|Abstract »|Full Text »|PDF »
Role of Lactate in Lipid Metabolism, Just Always Inhibiting Lipolysis?.